Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objectives of this study are to evaluate the efficacy and safety of adalimumab given subcutaneously every other week (eow) as compared to placebo in pediatric subjects with Enthesitis Related Arthritis (ERA), and to examine the pharmacokinetics and immunogenicity of adalimumab following SC administration in this subject population.
Critère d'inclusion
- Enthesitis Related Arthritis (ERA)